Accelmed Partners is a lower middle-market private equity firm focused on acquiring and investing in U.S. commercial-stage HealthTech companies. For more than a decade, we have leveraged our deep HealthTech industry experience, operational and financial expertise, and strong relationships to help management teams at companies across the medical device, tools, diagnostics, digital health and tech-enabled services sectors position their businesses for future growth and success. Our ideal partners share our values of integrity, transparency and tenacity, directed toward leveraging technology to improve patient outcomes, reduce costs and increase efficiency throughout the healthcare system. We currently manage over $630 million of equity capital and are actively investing out of our second private equity fund, Accelmed Partners II.